CTU: A Phase II, Randomized, Multicenter, Open-label, Controlled Study of RO7247669 Alone or in Combination with Tiragolumab versus Atezolizumab in Patients with Previously Untreated Locally Advanced or Metastitic Urothelial Cancer who are Ineligible for Platinum-containing Chemotherapy

  • Zhang, Alison (Primary Chief Investigator)
  • Contacos, Christine (Clinical Trial Unit Staff)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • Morrisroe, Emma (Clinical Trial Unit Staff)
  • Keshiya, Shikara (Clinical Trial Unit Staff)
  • Chester, Catherine (Clinical Trial Unit Staff)

Project: Research

Project Details

Short titleBO44157
AcronymBO44157
StatusActive
Effective start/end date5/05/2317/04/28